Menu
Pulmonology / Respiratory

HIV-Associated PAH

ICD-10 Code
I27.21_5

Clinical Criteria for HIV-Associated PAH.

Clinical Presentation & Protocol

Patient Usually Complains Of

Patient is a known HIV-positive individual presenting with progressive exertional dyspnea (NYHA Class [I-IV]), fatigue, and decreased exercise tolerance. Denies orthopnea or paroxysmal nocturnal dyspnea. No history of illicit stimulant use. Current ART regimen: [Insert Regimen]. Symptoms are consistent with suspected HIV-associated pulmonary arterial hypertension.

Clinical Examination Findings

Cardiovascular exam reveals a loud P2, a right-sided S4 gallop, and a holosystolic murmur at the left sternal border consistent with tricuspid regurgitation. Jugular venous distension (JVD) noted. Lower extremities show [0/1+/2+] pitting edema. Lungs are clear to auscultation bilaterally. No evidence of hepatomegaly or ascites.

Treatment Protocol

Initiate optimization of ART therapy. Start PAH-specific targeted therapy: [PDE5 inhibitor / Endothelin receptor antagonist / Prostacyclin analogue]. Monitor for drug-drug interactions between ART and PAH medications. Schedule repeat TTE and 6-minute walk test (6MWT) in [X] weeks. Refer to pulmonary hypertension center for right heart catheterization.

Detailed clinical guide coming soon.